TherapeuticsMD, Inc.
Current role
TXMD
Paul M. Bisaro
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Paul M. Bisaro
TherapeuticsMD, Inc. reported in an 8-K filed January 3, 2023 that Paul M. Bisaro resigned as board of directors, effective December 30, 2022.
“On December 30, 2022, each of Mr. Paul M. Bisaro, Ms. Karen L. Ling, Mr. Jules A. Musing and Mr. Angus C. Russell resigned from the board of directors (the "Board") of the Company, and any committees thereof, effective upon the closing of the Transaction.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
TherapeuticsMD, Inc. (TXMD)
SEC 8-K
Current2020-04-20–present
-
2021-05-27–2022-12-30
-
Start not stated–2022-12-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at TherapeuticsMD, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Bernick CEO
- Mark Glickman CEO
- Marlan D. Walker CEO, General Counsel
- Robert Finizio CEO, Board Member
- Tommy G. Thompson Chairman, Board Member
- Tommy Thompson Chairman
- James C. D'Arecca CFO
- Joseph Ziegler CFO
- Adam Miller CIO
- Cooper C. Collins Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.